# Bupivacaine Verus Pethidine for Post Cesarean Section Pain Relief

> **NCT03652116** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 78 (actual)

## Conditions studied

- Obstetric Pain

## Interventions

- **DRUG:** Wound infiltration by Bupivacaine
- **DRUG:** Wound infiltration by Pethidine

## Key facts

- **NCT ID:** NCT03652116
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-21
- **Primary completion:** 2018-06-10
- **Final completion:** 2018-08-01
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03652116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03652116, "Bupivacaine Verus Pethidine for Post Cesarean Section Pain Relief". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03652116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*